Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 321

1.

Surgical Management and Oncologic Outcomes of Recurrent Venous Tumor Thrombus after Prior Nephrectomy for Renal Cell Carcinoma.

Parker WP, Boorjian SA, Zaid HB, Cheville JC, Leibovich BC, Thompson RH.

Eur Urol Focus. 2016 Dec 15;2(6):625-630. doi: 10.1016/j.euf.2016.05.003. Epub 2016 Jul 7.

PMID:
28723495
2.

Oncologic surveillance following radical cystectomy: an individualized risk-based approach.

Merrill SB, Boorjian SA, Thompson RH, Psutka SP, Cheville JC, Thapa P, Tollefson MK, Frank I.

World J Urol. 2017 Jul 6. doi: 10.1007/s00345-017-2068-7. [Epub ahead of print]

PMID:
28685181
3.

Coffee consumption and risk of renal cell carcinoma.

Antwi SO, Eckel-Passow JE, Diehl ND, Serie DJ, Custer KM, Arnold ML, Wu KJ, Cheville JC, Thiel DD, Leibovich BC, Parker AS.

Cancer Causes Control. 2017 Aug;28(8):857-866. doi: 10.1007/s10552-017-0913-z. Epub 2017 Jun 24.

PMID:
28647866
4.

Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma.

Casuscelli J, Weinhold N, Gundem G, Wang L, Zabor EC, Drill E, Wang PI, Nanjangud GJ, Redzematovic A, Nargund AM, Manley BJ, Arcila ME, Donin NM, Cheville JC, Thompson RH, Pantuck AJ, Russo P, Cheng EH, Lee W, Tickoo SK, Ostrovnaya I, Creighton CJ, Papaemmanuil E, Seshan VE, Hakimi AA, Hsieh JJ.

JCI Insight. 2017 Jun 15;2(12). pii: 92688. doi: 10.1172/jci.insight.92688. [Epub ahead of print]

5.

Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis.

Bhindi B, Frank I, Mason RJ, Tarrell RF, Thapa P, Cheville JC, Costello BA, Pagliaro LC, Karnes RJ, Thompson RH, Tollefson MK, Boorjian SA.

Eur Urol. 2017 May 22. pii: S0302-2838(17)30406-2. doi: 10.1016/j.eururo.2017.05.016. [Epub ahead of print]

PMID:
28545841
6.

Are We Using the Best Tumor Size Cut-Points for Renal Cell Carcinoma Staging?

Bhindi B, Lohse CM, Mason RJ, Westerman ME, Cheville JC, Tollefson MK, Boorjian SA, Thompson RH, Leibovich BC.

Urology. 2017 Apr 12. pii: S0090-4295(17)30357-6. doi: 10.1016/j.urology.2017.04.010. [Epub ahead of print]

PMID:
28412331
7.

Severity of Preoperative Proteinuria is a Risk Factor for Overall Mortality in Patients Undergoing Nephrectomy.

Yang DY, Thompson RH, Zaid HB, Lohse CM, Rule AD, Boorjian SA, Leibovich BC, Cheville JC, Tollefson MK.

J Urol. 2017 Apr 8. pii: S0022-5347(17)45432-2. doi: 10.1016/j.juro.2017.04.016. [Epub ahead of print]

PMID:
28396181
8.

TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management.

Gupta S, Johnson SH, Vasmatzis G, Porath B, Rustin JG, Rao P, Costello BA, Leibovich BC, Thompson RH, Cheville JC, Sukov WR.

Mod Pathol. 2017 Jul;30(7):998-1012. doi: 10.1038/modpathol.2017.24. Epub 2017 Mar 24.

PMID:
28338654
9.

BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor.

Eckel-Passow JE, Serie DJ, Cheville JC, Ho TH, Kapur P, Brugarolas J, Thompson RH, Leibovich BC, Kwon ED, Joseph RW, Parker AS.

BMC Urol. 2017 Mar 21;17(1):19. doi: 10.1186/s12894-017-0209-3.

10.

Genomic tests to guide prostate cancer management following diagnosis.

Colicchia M, Morlacco A, Cheville JC, Karnes RJ.

Expert Rev Mol Diagn. 2017 Apr;17(4):367-377. doi: 10.1080/14737159.2017.1302332. Epub 2017 Mar 13.

PMID:
28277880
11.

Prognostic significance of lymphatic, vascular and perineural invasion for bladder cancer patients treated by radical cystectomy.

Muppa P, Gupta S, Frank I, Boorjian SA, Karnes RJ, Thompson RH, Thapa P, Tarrell RF, Herrera Hernandez LP, Jimenez RE, Cheville JC.

Pathology. 2017 Apr;49(3):259-266. doi: 10.1016/j.pathol.2016.12.347. Epub 2017 Mar 1.

PMID:
28259358
12.

Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection.

Gershman B, Moreira DM, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC.

Eur Urol. 2017 Aug;72(2):300-306. doi: 10.1016/j.eururo.2016.12.027. Epub 2017 Jan 13.

PMID:
28094055
13.

Clinical and surgical management of a congenital Type II split cord malformation presenting with progressive cranial neuropathies: case report.

Maloney PR, Murphy ME, Sullan MJ, Van Abel KM, Cofer SA, Cheville JC, Wetjen NM.

J Neurosurg Pediatr. 2017 Mar;19(3):349-353. doi: 10.3171/2016.9.PEDS15661. Epub 2016 Dec 23.

PMID:
28009225
14.

Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes.

Ho TH, Serie DJ, Parasramka M, Cheville JC, Bot BM, Tan W, Wang L, Joseph RW, Hilton T, Leibovich BC, Parker AS, Eckel-Passow JE.

Ann Oncol. 2017 Mar 1;28(3):604-610. doi: 10.1093/annonc/mdw652.

PMID:
27993815
15.

Patient factors associated with 30-day complications after partial nephrectomy: A contemporary update.

Zaid HB, Parker WP, Lohse CM, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH.

Urol Oncol. 2017 Apr;35(4):153.e1-153.e6. doi: 10.1016/j.urolonc.2016.11.001. Epub 2016 Dec 6.

PMID:
27939815
16.

Clinical Reasoning: An unusual cause of indeterminate spells.

Feyissa AM, Kenney-Jung DL, Shin C, Cheville JC, So EL.

Neurology. 2016 Dec 6;87(23):e275-e280. No abstract available.

PMID:
27920289
17.

Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness.

Serie DJ, Joseph RW, Cheville JC, Ho TH, Parasramka M, Hilton T, Thompson RH, Leibovich BC, Parker AS, Eckel-Passow JE.

Eur Urol. 2017 Jun;71(6):979-985. doi: 10.1016/j.eururo.2016.11.018. Epub 2016 Nov 26.

PMID:
27899233
18.

Outcomes Following Radical Cystectomy for Plasmacytoid Urothelial Carcinoma: Defining the Need for Improved Local Cancer Control.

Cockerill PA, Cheville JC, Boorjian SA, Blackburne A, Thapa P, Tarrell RF, Frank I.

Urology. 2017 Apr;102:143-147. doi: 10.1016/j.urology.2016.09.053. Epub 2016 Nov 16.

PMID:
27865750
19.

Urinary collecting system invasion is associated with poor survival in patients with clear-cell renal cell carcinoma.

Bailey GC, Boorjian SA, Ziegelmann MJ, Westerman ME, Lohse CM, Leibovich BC, Cheville JC, Thompson RH.

BJU Int. 2017 Apr;119(4):585-590. doi: 10.1111/bju.13669. Epub 2016 Oct 20.

PMID:
27696652
20.

Renal Leiomyoma and Leiomyosarcoma: A Study of 57 Cases.

Gupta S, Jimenez RE, Folpe AL, Cheville JC.

Am J Surg Pathol. 2016 Nov;40(11):1557-1563.

PMID:
27276240

Supplemental Content

Loading ...
Support Center